Contact us digitally
Contact our skilled medical secretaries via Capio Online Service. Login with MitID so you can get your questions answered safely and securely. We are ready to answer your inquiries within opening hours.
Simon Fage
Specialist in dermatology and venereology
Affiliated departments
Capio Aalborg
Capio Aarhus
Capio Odense
Introduction
Special competencies
- Skin cancer and melanoma and their precursors
- Inflammatory skin diseases (including eczema, psoriasis, acne, rosacea)
- Connective tissue diseases / rheumatic skin diseases
Education and training
2011, Cand.med., Aarhus University
2019, Specialist in dermato-venereology
Experience
Specialist physician/department physician, Skin and Venereal Diseases, Aarhus University Hospital, 2019-2023
Specialist physician, Clinical Research Unit, Skin and Venereal Diseases, Aarhus University Hospital, 2019-2023
Resident physician, intro and main education, Skin and Venereal Diseases, AUH-OUH-AUH, 2014-2019
Consultant (skin diseases), Mølholm Private Hospital, 2018-2019
Resident physician, secondary education, Department of Infectious Diseases Q, Aarhus University Hospital, 2015
Resident physician, intro education, Department of Renal Medicine, Herlev Hospital, 2012-2013
Resident physician, Department of Renal Medicine, Aalborg University Hospital, 2012
General practitioner and on-call doctor, Kommunelegen in Suldal, Norway, 2012
General practitioner, Læge- og sygeplejeklinikken, Hadsund, 2012
Resident physician, Department of Rheumatology, Frederiksberg Hospital, 2011-2012
Resident physician, Department of Orthopedic Surgery, Hvidovre Hospital, 02/2011 - 08/2011
Substitute for resident physician, Aalborg Psychiatric Hospital, 2010
Substitute for resident physician, Department of Renal Medicine and Department of Endocrinology, Aalborg University Hospital, 2009-2010
Substitute for resident physician, Department of Renal Medicine, Aalborg University Hospital, 2009
Other information
Academic work
Fage SW, Muris J, Jakobsen SS, Thyssen JP. Titanium: a review on exposure, release, penetration, allergy, epidemiology and clinical reactivity. Contact Dermatitis. 2016 Jun;74(6):323-45
Fage SW, Faurschou A, Thyssen JP, Copper hypersensitivity, Contact Dermatitis, 2014 Oct;71(4):191-201.
Simon W. Fage. Metal Allergy: Copper. Metal Allergy: From Dermatitis to Implant and Device Failure. Eds. Jennifer K. Chen and Jacob P. Thyssen. ISBN: 978-3-3-319-58502-4 (11 pages)
Fage SW, Iftner T, Thyssen JP, Kjaer SK. Filaggrin, Human Papillomavirus, and the Cervix. Filaggrin. Basic Science, Epidemiology, Clinical Aspects and Management (Thyssen and Maibach, eds.), Springer 2014 (p. 333-342)
Fage SW, Arvesen KB, Olesen AB. Abatacept Improves Skin-score and Reduces Lesions in Patients with Localized Scleroderma: A Case Series. Acta Derm Venereol. 2018 Apr 16;98(4):465-466
Fage SW, Olsen AB. Dysthrophic calcification in Systemic Sclerosis - Intralesional Injections of Sodium Thiosulfate may have significant Positive Effects on your patients. Medical Research Archives vol 8 issue 5. May 2020
Loft N, Bregnhøj A, Fage S, Nielsen CH, Enevold C, Zachariae C, Iversen L, Skov L. Effectiveness of brodalumab after previous treatment failure of interleukin-17A inhibitors in patients with psoriasis. Dermatol Ther. 2021 Aug 21:e15106. doi: 10.111111/dth.15106. Epub ahead of print. PMID: 34418225.
Andersen SM, Fage S, Rubak SL, Holm M, Jensen JMB, Mogensen T, Deleuran M. Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome Manifesting as Lymphocytic Interstitial Pneumonia and Treatment-Resistant Bullous Pemphigoid. Pediatr Allergy Immunol Pulmonol. 2021 Jun;34(2):76-79. doi: 10.1089/ped.2020.1307. PMID: 34143686; PMCID: PMC8329723.
Mette Gyldenløve; Howraman Meteran; Jennifer Astrup Sørensen; Simon Fage; Yiqiu Yao; Jesper Lindhardsen; Christoffer Valdemar Nissen; Tanja Todberg; Simon Francis Thomsen; Lone Skov; Claus Zachariae; Lars Iversen; Mia-Louise Nielsen; Alexander Egeberg. Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis - a randomized controlled trial (PSORRO) (under review, Lancet)
Simon Fage, Claus Johansen. Severe and therapeutic challenging oral erosive lichen planus treated with oral roflumilast (accepted, Clinical and Experimental Dermatology)
Clinical research
EXP-1373, Leo Pharma (cutaneous lupus erythematosus) (primary investigator)
RD.06.SPR.202685, Galderma (prurigo nodularis) (primary investigator)
RD.06.SPR.202699, Galderma (prurigo nodularis) (primary investigator)
JAHN(7), Lilly (atopic dermatitis)
M16-045, AbbVie (atopic dermatitis)
M18-891, AbbVie (atopic dermatitis)
AIN457 (SUNRISE), Novartis (hidrosadenitis suppurativa)
INCB 54707-203, Incyte corp. (hidrosadenitis suppurativa)
LP0133-1273, Leo Pharma (chronic hand eczema)
PsoPET2, Leo Pharma (psoriasis)
2018-PSO-IL17R, investigator initiated, LEO Pharma (psoriasis)
SMR-3612, Almirall (psoriasis)
CUDC 305, Innovaderm Research Inc (psoriasis)
STEPIn (CAIN457A2322), Novartis (psoriasis)
CLOU064A2201, Novartis (chronic hives)
CLOU064A2201E1 (ext.), Novartis (chronic hives)
HS0003, ucb (hidrosadenitis suppurativa)
PSORRO, investigator initiated (psoriasis)
Delta 2+3, Leo Pharma (chronic hand eczema)
M23-696, Abbvie (atopic dermatitis)